Who makes n-3 fatty acids?

n-3 fatty acids is developed by University Hospital, Basel, Switzerland.

What development phase is n-3 fatty acids in?

n-3 fatty acids is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

n-3 fatty acids

University Hospital, Basel, Switzerland · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	n-3 fatty acids
Sponsor	University Hospital, Basel, Switzerland
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction (PHASE2)
Pre-Surgical Immunonutrition's Effect on Colorectal Surgery (NA)
Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia (PHASE2)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (PHASE2)
Heart & Health Study (NA)
NMDA Enhancement Combined With Omega-3 for Early Dementia (PHASE2)
A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth (PHASE4)
Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen? (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

n-3 fatty acids CI brief — competitive landscape report
n-3 fatty acids updates RSS · CI watch RSS
University Hospital, Basel, Switzerland portfolio CI